Published in Can Psychiatr Assoc J on June 01, 1972
Teaching history-taking: where are we? Yale J Biol Med (1980) 0.75
The ATP 30-a scale for measuring medical students' attitudes to psychiatry. Med Educ (1982) 1.81
Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis (2007) 1.73
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2). Transplantation (2002) 1.64
Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol (1995) 1.48
Balancing utility and need by means of donor-to-recipient matching: a challenging problem. Am J Transplant (2013) 1.43
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation. J Hepatol (2001) 1.19
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology (1992) 1.12
Nonadherent behaviors after solid organ transplantation. Transplant Proc (2011) 1.12
Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology (1994) 1.05
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant (2007) 1.03
Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat (2007) 1.02
Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis (2009) 1.01
Bone metabolism in orthotopic liver transplantation: a prospective study. Liver Transpl Surg (1998) 0.99
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc (2006) 0.98
Veno occlusive disease: update on clinical management. World J Gastroenterol (2007) 0.98
Therapeutic advantage of bifrontal electrode placement in ECT. Psychol Med (1993) 0.97
The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J Hepatol (2000) 0.93
Histology predicts cirrhotic evolution of post transplant hepatitis C. Gut (2002) 0.89
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant (2011) 0.88
De novo tumors are a major cause of late mortality after orthotopic liver transplantation. Transplant Proc (2009) 0.88
Electrode placement in ECT: cognitive effects. Psychol Med (1990) 0.88
Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4,767 recipients in Italy, 1970-2006. Transplant Proc (2009) 0.87
Microwave thermal ablation for hepatocarcinoma: six liver transplantation cases. Transplant Proc (2011) 0.87
Electrical dose and seizure threshold: relations to clinical outcome and cognitive effects in bifrontal, bitemporal, and right unilateral ECT. J ECT (2000) 0.86
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. Transplant Proc (2009) 0.86
Serum malondialdehyde and mitochondrial aspartate aminotransferase activity as markers of chronic alcohol intake and alcoholic liver disease. Ital J Gastroenterol (1993) 0.86
HBV and HCV infections in heart transplant recipients. J Heart Lung Transplant (2001) 0.86
The protective effects of L-arginine after liver ischaemia/reperfusion injury in a pig model. J Pathol (1997) 0.86
Alcohol abuse and de novo tumors in liver transplantation. Transplant Proc (2009) 0.85
Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation? Transplant Proc (2009) 0.84
The impact of hepatitis C and biliary complications on patient and graft survival following liver transplantation. Am J Transplant (2009) 0.84
Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report. Biol Trace Elem Res (1995) 0.83
Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review. Transplant Proc (2010) 0.82
Untoward effects following combined neuroleptic-lithium therapy. Cardiac arrhythmias and seizure. Can J Psychiatry (1980) 0.81
11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease. J Clin Endocrinol Metab (1993) 0.81
Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation. Transplant Proc (2005) 0.81
Teaching interviewing skills by encountering patients. J Med Educ (1979) 0.81
Prognostic evaluation of the donor risk index among a prospective cohort of Italian patients undergoing liver transplantation. Transplant Proc (2009) 0.81
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection. Transpl Int (2000) 0.81
Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs. Ital J Gastroenterol (1992) 0.80
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transplant Proc (2010) 0.80
Microvascular autonomic dysfunction may justify false-positive stress myocardial perfusion imaging in patients with liver cirrhosis undergoing liver transplantation. Transplant Proc (2008) 0.79
The transjugular route: the key hole to the liver world. Dig Liver Dis (2006) 0.79
Management of hepatitis C virus infection recurrence after liver transplantation: an overview. Transplant Proc (2011) 0.79
Regional cerebral blood flow changes in patients with cirrhosis assessed with 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. J Hepatol (1998) 0.79
Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment. Acta Haematol (2008) 0.78
The effect of recurrence of HCV infection of life after liver transplantation. Transpl Int (1998) 0.78
Early predictive markers of irreversible graft dysfunction after liver transplantation. Transplant Proc (1994) 0.78
Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation. Transplant Proc (2011) 0.78
Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporos Int (2001) 0.77
[A clinico-endoscopic study on cicatrization of lesions and prevention of recurrences in patients with liver cirrhosis and peptic ulcer]. G Clin Med (1990) 0.77
A typical psychosis with reversible primitive reflexes. Can J Psychiatry (1980) 0.77
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation? Transplant Proc (2012) 0.77
Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience. Anticancer Res (2010) 0.77
Risk factors in liver retransplantation: a single-center experience. Transplant Proc (2011) 0.77
Combined liver and kidney transplantation: analysis of Padova experience. Transplant Proc (2007) 0.77
Laboratory test scores to aid identification of primary nonfunction of liver transplants. Clin Chem (1995) 0.76
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. Transplant Proc (2013) 0.76
Aprotinin efficacy on intraoperative bleeding and transfusion requirements in orthotopic liver transplantation. Transfusion (1994) 0.76
Role-playing: a method of teaching interpersonal skills. Can Psychiatr Assoc J (1972) 0.76
Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients. Transplant Proc (2009) 0.76
HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma. Transplant Proc (2008) 0.76
Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910-916). Br J Surg (2010) 0.75
Hepatitis C infection in patients with chronic kidney disease. Int J Artif Organs (2008) 0.75
Managing severe alcoholic hepatitis complicated by renal failure. Q J Med (1993) 0.75
Natural alpha-IFN in HCV recurrence after liver transplantation. Transplant Proc (2001) 0.75
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing. Transplant Proc (2003) 0.75
Liver transplantation and pregnancy. Int J Gynaecol Obstet (1995) 0.75
[Neuroendocrine tumors and liver transplantation: review based on a case report]. Orv Hetil (1997) 0.75
Characteristics of responders and nonresponders to brief-pulse right unilateral ECT in a controlled clinical trial. J ECT (2001) 0.75
The metaphysical nature of psychotherapy. Am J Psychiatry (1980) 0.75
A case of atypical depression. Can J Psychiatry (1988) 0.75
Gastrectomy, lack of gastric first pass metabolism of ethanol and alcoholic liver disease. Results of a multicentre study. Ital J Gastroenterol Hepatol (1997) 0.75
[Ulcer and hepatic cirrhosis. Epidemiologic and clinical correlations]. Minerva Med (1991) 0.75
Physiological and clinical implications of proANP(1-98) circulating levels in the perioperative phase of liver transplantation. Clin Chim Acta (2001) 0.75
Operant management of the behavioural sequelae of Wilson's disease: a case report. Can Psychiatr Assoc J (1978) 0.75
Are the renal effects of lithium modified by frequency of administration? Acta Psychiatr Scand (1995) 0.75
Locophobia--a case report. Psychiatr Q (1970) 0.75
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance. Transplant Proc (2000) 0.75
Symposium on the teaching of psychiatry. Canada: Queen's University, Kingston, Ontario. Br J Psychiatry (1983) 0.75
GH/GHBP changes in the perioperative course of liver transplantation: pathophysiologic and clinical implications. Transplant Proc (2001) 0.75
Comparison of depression inventories in a clinical population. Can Psychiatr Assoc J (1976) 0.75
[Preservation of the liver with the University of Wisconsin solution. Clinical and experimental aspects]. Minerva Gastroenterol Dietol (1992) 0.75
Mental competence and consent to treatment. Can J Psychiatry (1980) 0.75
Two cases of Kaposi's sarcoma in renal and liver transplant recipients treated with interferon. Clin Transplant (1996) 0.75
Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis. Eur J Cancer Prev (1992) 0.75
Functional and morphological graft monitoring after liver transplantation. Clin Chim Acta (2001) 0.75
Protective effect of L-arginine on liver ischemia-reperfusion injury. Transplant Proc (1997) 0.75
Primary biliary cirrhosis: symptomatic treatment. J Gastroenterol Hepatol (1992) 0.75
Sleep deprivation in depression: pattern of relapse and characteristics of preceding sleep. Biol Psychiatry (1990) 0.75
Human natriuretic factor in cirrhotic patients undergoing orthotopic liver transplantation. Transpl Int (1995) 0.75
A new type of facility in medical education: the Clinical Learning Center. J Med Educ (1975) 0.75
Energy expenditure (EE) and substrate utilization (SU) in the perioperative period in orthotopic liver transplantation (OLTX). Rocz Akad Med Bialymst (1995) 0.75
Histological features of donor grafts for orthotopic liver transplantation. Transplant Proc (2001) 0.75
The Helping Professions Group: interpersonal dimensions in health sciences education. J Med Educ (1979) 0.75